![[CytoReason in No Camels] cytoreason teams up with merck kgaa on cancer drug development](https://blog.ourcrowd.com/wp-content/uploads/2017/10/nocamels-NEW.jpg)
[ad_1]
Israeli biotech startup CytoReason announced Wednesday that it is collaborating with German multinational science and technology company, Merck KGaA, Darmstadt, Germany, to profile one of its leading immuno-oncology drugs.
Read more here.
[ad_2]
Source link
Own and operated by The Ike Lemuwa Group, LLC a Commonwealth of Virginia Limited Liability Company, USA.
Info@nigeriasmartnews.com / info@ikelemuwagroup.com
Toll-Free: 1 888 642 8433
3821 Dominion Drive Dumfries, Virginia, 22026. USA
